Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
RESEARCH TOOLSreports
Holding OBIO?
Track your performance easily
OBIO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.22 - $11.69
Previous Close$5.44
Volume32.42K
Average Volume (3M)59.18K
Market Cap
$206.79M
Enterprise Value$141.71M
Total Cash (Recent Filing)$66.93M
Total Debt (Recent Filing)$1.84M
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Mar 26, 2025EPS Estimate
-$0.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.59
Shares Outstanding38,013,526
10 Day Avg. Volume64,333
30 Day Avg. Volume59,184
Standard Deviation0.24
R-Squared0.00654
Alpha0.00484
Financial Highlights & Ratios
Price to Book (P/B)4.33
Price to Sales (P/S)74.25
Price to Cash Flow (P/CF)-3.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue53.53
Enterprise Value/Gross Profit55.05
Enterprise Value/Ebitda-2.45
Forecast
1Y Price Target
$17.00Price Target Upside194.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Orchestra BioMed Holdings News
PremiumCompany Announcements
Orchestra Biomed Reports Q3 2024 Financial Results
PremiumCompany Announcements
Orchestra BioMed Bolsters Board with Strategic Appointment
Ownership Overview
11.70% Insiders
6.85% Mutual Funds
34.52% Other Institutional Investors
40.89% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
OBIO FAQ
What was Orchestra BioMed Holdings’s price range in the past 12 months?
Orchestra BioMed Holdings lowest stock price was $4.22 and its highest was $11.69 in the past 12 months.
What is Orchestra BioMed Holdings’s market cap?
Currently, no data Available
When is Orchestra BioMed Holdings’s upcoming earnings report date?
Orchestra BioMed Holdings’s upcoming earnings report date is Mar 26, 2025 which is in 123 days.
How were Orchestra BioMed Holdings’s earnings last quarter?
Orchestra BioMed Holdings released its earnings results on Nov 12, 2024. The company reported -$0.41 earnings per share for the quarter, beating the consensus estimate of -$0.43 by $0.02.
Is Orchestra BioMed Holdings overvalued?
According to Wall Street analysts Orchestra BioMed Holdings’s price is currently Undervalued.
Does Orchestra BioMed Holdings pay dividends?
Orchestra BioMed Holdings does not currently pay dividends.
What is Orchestra BioMed Holdings’s EPS estimate?
Orchestra BioMed Holdings’s EPS estimate is -$0.43.
How many shares outstanding does Orchestra BioMed Holdings have?
Orchestra BioMed Holdings has 38,013,527 shares outstanding.
What happened to Orchestra BioMed Holdings’s price movement after its last earnings report?
Orchestra BioMed Holdings reported an EPS of -$0.41 in its last earnings report, beating expectations of -$0.43. Following the earnings report the stock price went up 7.244%.
Which hedge fund is a major shareholder of Orchestra BioMed Holdings?
Among the largest hedge funds holding Orchestra BioMed Holdings’s share is Perceptive Advisors LLC. It holds Orchestra BioMed Holdings’s shares valued at 24M.
---
Orchestra BioMed Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.00 (194.63% Upside)
$17.00 (194.63% Upside)
Hedge Fund Trend
Increased
By 2.0M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $177.7K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.09%
12-Months-Change
Fundamentals
Return on Equity
-91.66%
Trailing 12-Months
Asset Growth
-35.27%
Trailing 12-Months
Company Description
Orchestra BioMed Holdings
Health Sciences Acquisitions Corp 2 is a blank check company.
---
OBIO Stock 12 Month Forecast
Average Price Target
$17.00
▲(194.63% Upside)
Technical Analysis
Best Analysts Covering OBIO
1 Year
1 Year Success Rate
4/10 ratings generated profit
1 Year Average Return
-10.48%
reiterated a buy rating 11 days ago
Copying Keay Nakae's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -10.48% per trade.
---